Warning: The NCBI web site requires JavaScript to function. more...
Commentary on Vorobjov et al., "Comparison of injection drug users who obtain syringes from pharmacies and syringe exchange programs in Tallinn, Estonia".
Werb D, Wood E.
Harm Reduct J. 2009 Nov 27;6:33.
Related citations
Comparison of injecting drug users who obtain syringes from pharmacies and syringe exchange programs in Tallinn, Estonia.
Vorobjov S, Uusküla A, Abel-Ollo K, Talu A, Rüütel K, Des Jarlais DC.
Harm Reduct J. 2009 Feb 20;6:3.
Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal.
Neaigus A, Zhao M, Gyarmathy VA, Cisek L, Friedman SR, Baxter RC.
J Urban Health. 2008 May;85(3):309-22. Epub 2008 Mar 14.
Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities.
Bluthenthal RN, Malik MR, Grau LE, Singer M, Marshall P, Heimer R; Diffusion of Benefit through Syringe Exchange Study Team.
Addiction. 2004 Sep;99(9):1136-46.
Should pharmacists have a role in harm reduction services for IDUs? A qualitative study in Tallinn, Estonia.
Vorobjov S, Uusküla A, Abel-Ollo K, Talu A, Jarlais DD.
J Urban Health. 2009 Nov;86(6):918-28. Epub 2009 Nov 18.
Pharmacy access to syringes among injecting drug users: follow-up findings from Hartford, Connecticut.
Singer M, Baer HA, Scott G, Horowitz S, Weinstein B.
Public Health Rep. 1998 Jun;113 Suppl 1:81-9.
Expanded syringe exchange programs and reduced HIV infection among new injection drug users in Tallinn, Estonia.
Uusküla A, Des Jarlais DC, Kals M, Rüütel K, Abel-Ollo K, Talu A, Sobolev I.
BMC Public Health. 2011 Jun 30;11:517.
An economic analysis of needle exchange and pharmacy-based programs to increase sterile syringe availability for injection drug users.
Lurie P, Gorsky R, Jones TS, Shomphe L.
J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S126-32.
Effects of increasing syringe availability on syringe-exchange use and HIV risk: Connecticut, 1990-2001.
Heimer R, Clair S, Teng W, Grau LE, Khoshnood K, Singer M.
J Urban Health. 2002 Dec;79(4):556-70.
HIV infection among intravenous drug users: epidemiology and risk reduction.
Des Jarlais DC, Friedman SR.
AIDS. 1987 Jul;1(2):67-76. Review.
Impact of pharmacy-based syringe access on injection practices among injecting drug users in Minnesota, 1998 to 1999.
Cotten-Oldenburg NU, Carr P, DeBoer JM, Collison EK, Novotny G.
J Acquir Immune Defic Syndr. 2001 Jun 1;27(2):183-92.
Syringe laws and pharmacy regulations are structural constraints on HIV prevention in the US.
Taussig JA, Weinstein B, Burris S, Jones TS.
AIDS. 2000 Jun;14 Suppl 1:S47-51.
Access to syringes in three Russian cities: implications for syringe distribution and coverage.
Sarang A, Rhodes T, Platt L.
Int J Drug Policy. 2008 Apr;19 Suppl 1:S25-36. Epub 2008 Mar 3.
Difficulty accessing syringes and syringe borrowing among injection drug users in Bangkok, Thailand.
Kerr T, Fairbairn N, Hayashi K, Suwannawong P, Kaplan K, Zhang R, Wood E.
Drug Alcohol Rev. 2010 Mar;29(2):157-61.
Examination of the association between syringe exchange program (SEP) dispensation policy and SEP client-level syringe coverage among injection drug users.
Bluthenthal RN, Ridgeway G, Schell T, Anderson R, Flynn NM, Kral AH.
Addiction. 2007 Apr;102(4):638-46. Epub 2007 Feb 6.
A sterile syringe for every drug user injection: how many injections take place annually, and how might pharmacists contribute to syringe distribution?
Lurie P, Jones TS, Foley J.
J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18 Suppl 1:S45-51.
A longitudinal study of syringe acquisition by Puerto Rican injection drug users in New York and Puerto Rico: implications for syringe exchange and distribution programs.
Finlinson HA, Oliver-Vélez D, Deren S, Cant JG, Colón HM, Robles RR, Kang SY, Andía JF.
Subst Use Misuse. 2006;41(9):1313-36.
Clean needles save lives. HIV and injecting drug use.
James B.
AIDS Action. 1993 Jun-Aug;(21):4-5.
Determinants of injection drug user (IDU) syringe sharing: the relationship between availability of syringes and risk network member characteristics in Winnipeg, Canada.
Shaw SY, Shah L, Jolly AM, Wylie JL.
Addiction. 2007 Oct;102(10):1626-35.
Unsafe injecting practices among attendees of syringe exchange programmes in France.
Valenciano M, Emmanuelli J, Lert F.
Addiction. 2001 Apr;96(4):597-606.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on